Clinical Trials Browser

Phase 3 × INDUSTRY × Advanced Prostate Adenocarcinoma × Clear all

NCT04914195 2023-08-01

Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

Phase 3 Completed

Advanced Prostate Adenocarcinoma